{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:01:09Z","timestamp":1787025669020,"version":"build-2736575974"},"reference-count":41,"publisher":"The Society for Free Radical Research Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2025]]},"DOI":"10.3164\/jcbn.25-74","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T22:07:51Z","timestamp":1755641271000},"page":"216-222","source":"Crossref","is-referenced-by-count":2,"title":["Oxidative modification of methionine residue in \u200d\u03b1-synuclein by dopamine induces cellular vulnerability, oligomerization and secretion of \u03b1-synuclein"],"prefix":"10.3164","volume":"77","author":[{"given":"Yugo","family":"Kato","sequence":"first","affiliation":[{"name":"Division of Biochemistry, Department of Pathophysiological and Therapeutic Sciences, Faculty of Medicine, Tottori University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kanatani","sequence":"additional","affiliation":[{"name":"Division of Biochemistry, Department of Pathophysiological and Therapeutic Sciences, Faculty of Medicine, Tottori University"},{"name":"Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Adachi","sequence":"additional","affiliation":[{"name":"Division of Neuropathology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Nagamine","sequence":"additional","affiliation":[{"name":"Division of Biochemistry, Department of Pathophysiological and Therapeutic Sciences, Faculty of Medicine, Tottori University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Horikoshi","sequence":"additional","affiliation":[{"name":"Division of Biochemistry, Department of Pathophysiological and Therapeutic Sciences, Faculty of Medicine, Tottori University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Nakaso","sequence":"additional","affiliation":[{"name":"Division of Biochemistry, Department of Pathophysiological and Therapeutic Sciences, Faculty of Medicine, Tottori University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Lees AJ, Hardy J, Revesz T. Parkinson\u2019s disease. Lancet 2009; 373: 2055\u20132066.","DOI":"10.1016\/S0140-6736(09)60492-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Mizuno Y, Hattori N, Kubo S, et al. Progress in the pathogenesis and genetics of Parkinson\u2019s disease. Philos Trans R Soc Lond B Biol Sci 2008; 363: 2215\u20132227.","DOI":"10.1098\/rstb.2008.2273"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 1998; 95: 6469\u20136473.","DOI":"10.1073\/pnas.95.11.6469"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Derkinderen P, Rouaud T, Lebouvier T, Bruley des Varannes S, Neunlist M, De Giorgio R. Parkinson disease: the enteric nervous system spills its guts. Neurology 2011; 77: 1761\u20131767.","DOI":"10.1212\/WNL.0b013e318236ef60"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson\u2019s disease. Eur Neurol 1997; 38 Suppl 2: 2\u20137.","DOI":"10.1159\/000113469"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Micieli G, Tosi P, Marcheselli S, Cavallini A. Autonomic dysfunction in Parkinson\u2019s disease. Neurol Sci 2003; 24 Suppl 1: S32\u2013S34.","DOI":"10.1007\/s100720300035"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Martin I, Dawson VL, Dawson TM. Recent advances in the genetics of Parkinson\u2019s disease. Annu Rev Genomics Hum Genet 2011; 12: 301\u2013325.","DOI":"10.1146\/annurev-genom-082410-101440"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Crosiers D, Theuns J, Cras P, Van Broeckhoven C. Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes. J Chem Neuroanat 2011; 42: 131\u2013141.","DOI":"10.1016\/j.jchemneu.2011.07.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Saiki S, Sato S, Hattori N. Molecular pathogenesis of Parkinson\u2019s disease: update. J Neurol Neurosurg Psychiatry 2012; 83: 430\u2013436.","DOI":"10.1136\/jnnp-2011-301205"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease. Nat Genet 2009; 41: 1303\u20131307.","DOI":"10.1038\/ng.485"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. \u03b1-Synuclein in Lewy bodies. Nature 1997; 388: 839\u2013840.","DOI":"10.1038\/42166"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Dickson DW, Liu W, Hardy J, et al. Widespread alterations of \u03b1-synuclein in multiple system atrophy. Am J Pathol 1999; 155: 1241\u20131251.","DOI":"10.1016\/S0002-9440(10)65226-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 1997; 276: 2045\u20132047.","DOI":"10.1126\/science.276.5321.2045"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat 2010; 31: 763\u2013780.","DOI":"10.1002\/humu.21277"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Singleton AB, Farrer M, Johnson J, et al. \u03b1-Synuclein locus triplication causes Parkinson\u2019s disease. Science 2003; 302: 841.","DOI":"10.1126\/science.1090278"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Chartier-Harlin MC, Kachergus J, Roumier C, et al. \u03b1-Synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 2004; 364: 1167\u20131169.","DOI":"10.1016\/S0140-6736(04)17103-1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Ib\u00e1\u00f1ez P, Bonnet AM, D\u00e9barges B, et al. Causal relation between \u03b1-synuclein gene duplication and familial Parkinson\u2019s disease. Lancet 2004; 364: 1169\u20131171.","DOI":"10.1016\/S0140-6736(04)17104-3"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Chandra S, Gallardo G, Fern\u00e1ndez-Chac\u00f3n R, Schl\u00fcter OM, S\u00fcdhof TC. \u03b1-Synuclein cooperates with CSP\u03b1 in preventing neurodegeneration. Cell 2005; 123: 383\u2013396.","DOI":"10.1016\/j.cell.2005.09.028"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Xu J, Kao SY, Lee FJ, Song W, Jin LW, Yankner BA. Dopamine-dependent neurotoxicity of \u03b1-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med 2002; 8: 600\u2013606.","DOI":"10.1038\/nm0602-600"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Ito S, Nakaso K, Imamura K, Takeshima T, Nakashima K. Endogenous catecholamine enhances the dysfunction of unfolded protein response and \u03b1-synuclein oligomerization in PC12 cells overexpressing human \u03b1-synuclein. Neurosci Res 2010; 66: 124\u2013130.","DOI":"10.1016\/j.neures.2009.10.005"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Teraoka M, Nakaso K, Kusumoto C, et al. Cytoprotective effect of chlorogenic acid against \u03b1-synuclein-related toxicity in catecholaminergic PC12 cells. J Clin Biochem Nutr 2012; 51: 122\u2013127.","DOI":"10.3164\/jcbn.D-11-00030"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Fujiwara H, Hasegawa M, Dohmae N, et al. \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002; 4: 160\u2013164.","DOI":"10.1038\/ncb748"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Chen L, Periquet M, Wang X, et al. Tyrosine and serine phosphorylation of \u03b1-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J Clin Invest 2009; 119: 3257\u20133265.","DOI":"10.1172\/JCI39088"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Giasson BI, Duda JE, Murray IV, et al. Oxidative damage linked to neurodegeneration by selective \u03b1-synuclein nitration in synucleinopathy lesions. Science 2000; 290: 985\u2013989.","DOI":"10.1126\/science.290.5493.985"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Shimura H, Schlossmacher MG, Hattori N, et al. Ubiquitination of a new form of \u03b1-synuclein by parkin from human brain: implications for Parkinson\u2019s disease. Science 2001; 293: 263\u2013269.","DOI":"10.1126\/science.1060627"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Leong SL, Pham CL, Galatis D, et al. Formation of dopamine-mediated \u03b1-synuclein-soluble oligomers requires methionine oxidation. Free Radic Biol Med 2009; 46: 1328\u20131337.","DOI":"10.1016\/j.freeradbiomed.2009.02.009"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Mazzulli JR, Armakola M, Dumoulin M, Parastatidis I, Ischiropoulos H. Cellular oligomerization of \u03b1-synuclein is determined by the interaction of oxidized catechols with a C-terminal sequence. J Biol Chem 2007; 282: 31621\u201331630.","DOI":"10.1074\/jbc.M704737200"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Nakaso K, Tajima N, Ito S, et al. Dopamine-mediated oxidation of methionine 127 in \u03b1-synuclein causes cytotoxicity and oligomerization of \u03b1-synuclein. PLoS One 2013; 8: e55068.","DOI":"10.1371\/journal.pone.0055068"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Nakaso K, Tajima N, Horikoshi Y, et al. The estrogen receptor \u03b2-PI3K\/Akt pathway mediates the cytoprotective effects of tocotrienol in a cellular Parkinson\u2019s disease model. Biochim Biophys Acta 2014; 1842: 1303\u20131312.","DOI":"10.1016\/j.bbadis.2014.04.008"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Yoshimoto Y, Nakaso K, Nakashima K. L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells. FEBS Lett 2005; 579: 1197\u20131202.","DOI":"10.1016\/j.febslet.2004.12.091"},{"key":"31","unstructured":"31 Rasband WS. ImageJ. U.S. National Institutes of Health, Bethesda, Maryland, USA, http:\/\/imagej.nih.gov\/ij\/, 1997\u20132012."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671\u2013675.","DOI":"10.1038\/nmeth.2089"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Sakuwa M, Adachi T, Yoshida K, Adachi Y, Nakano T, Hanajima R. An autopsy case of PARK2 due to a homozygous exon 2 deletion of parkin and associated with \u03b1-synucleinopathy. Neuropathology 2021; 41: 293\u2013300.","DOI":"10.1111\/neup.12735"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Lesage S, Anheim M, Letournel F, et al. G51D \u03b1-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann Neurol 2013; 73: 459\u2013471.","DOI":"10.1002\/ana.23894"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, et al. The new mutation, E46K, of \u03b1-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004; 55: 164\u2013173.","DOI":"10.1002\/ana.10795"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Vogt W. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic Biol Med 1995; 18: 93\u2013105.","DOI":"10.1016\/0891-5849(94)00158-G"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Kim HY, Gladyshev VN. Methionine sulfoxide reduction in mammals: characterization of methionine-R-sulfoxide reductases. Mol Biol Cell 2004; 15: 1055\u20131064.","DOI":"10.1091\/mbc.e03-08-0629"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Kantorow M, Lee W, Chauss D. Focus on molecules: methionine sulfoxide reductase A. Exp Eye Res 2012; 100: 110\u2013111.","DOI":"10.1016\/j.exer.2010.09.007"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Moskovitz J, Jenkins NA, Gilbert DJ, et al. Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proc Natl Acad Sci U S A 1996; 93: 3205\u20133208.","DOI":"10.1073\/pnas.93.8.3205"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Braak H, R\u00fcb U, Gai WP, Del Tredici K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna) 2003; 110: 517\u2013536.","DOI":"10.1007\/s00702-002-0808-2"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Jin M, Matsumoto S, Ayaki T, et al. DOPAnization of tyrosine in \u03b1-synuclein by tyrosine hydroxylase leads to the formation of oligomers. Nat Commun 2022; 13: 6880.","DOI":"10.1038\/s41467-022-34555-4"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/77\/3\/77_25-74\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:08:54Z","timestamp":1761970134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/77\/3\/77_25-74\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.25-74","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25-74"}}